Amgen has appointed David W. Meline as executive vice president and chief financial officer (CFO), effective July 21, 2014. He will be responsible for Amgen’s finance and investor relations operations, reporting to Robert A. Bradway , chairman and chief executive officer. Meline will succeed Michael A. Kelly , who served as acting CFO since January 2014.
Meline joins Amgen from 3M Company, where he most recently served as senior vice president and CFO, responsible for all financial activities for 3M across 70 countries of operation. Previously, Meline held numerous leadership positions at General Motors, He received his master of business administration in finance from the University of Chicago, his master of science in economics from the London School of Economics and his bachelor of science in mechanical engineering from Iowa State University.
